What are the risks and side effects of starting TRT in your 30s?

Short answer: Testosterone replacement therapy (TRT) can help men with truly low testosterone, but starting it in your 30s carries specific risks — most importantly suppression of fertility and sperm production — plus potential metabolic, hematologic, prostate, sleep and mood effects. Before starting, get a full evaluation and discuss fertility preservation and alternative therapies with a urologist or endocrinologist.

Main risks and side effects

• Fertility/testes

  • Suppressed spermatogenesis and reduced sperm count; can cause infertility while on TRT and sometimes prolonged or permanent impairment.
  • Testicular atrophy (smaller testes) from HPG-axis suppression.
  • If you want children, consider sperm banking before TRT or talk about fertility-preserving regimens (see options below).

• Hematologic

  • Increased red blood cell mass (erythrocytosis/polycythemia). This raises the risk of blood clots, stroke and heart attack. Common practice is to reduce/stop TRT or phlebotomy if hematocrit rises above concerning thresholds (clinicians often act around Hct >50–54%).

• Cardiovascular

  • Data are mixed. Some studies suggest increased cardiovascular risk in certain populations; others show neutral or beneficial effects. If you have heart disease, uncontrolled hypertension, prior clots, or multiple risk factors, risk-benefit must be carefully assessed.

• Prostate

  • TRT can raise PSA modestly. TRT is contraindicated in men with known prostate cancer. It does not clearly cause prostate cancer, but it can unmask existing disease — baseline PSA and digital rectal exam are standard.

• Metabolic and liver

  • Adverse effects on lipid profile have been reported (changes in HDL). Rare liver toxicity can occur (more with oral anabolic steroids than standard TRT). Monitor metabolic labs.

• Sleep and breathing

  • Worsening or new obstructive sleep apnea has been reported.

• Mood/behavior/neurologic

  • Improvements in mood and energy are common, but some men experience aggression, irritability, mood swings, or exacerbation of bipolar illness.

• Skin and fluid

  • Acne, oily skin, hair loss (male pattern baldness) and fluid retention.

• Gynecomastia

  • Possible due to peripheral conversion of testosterone to estrogen.

Other considerations

• Formulation matters: injectable testosterone (enanthate/cypionate) causes peaks/troughs and possible mood swings; transdermal gels/patches can cause transfer to others; long-acting injections (testosterone undecanoate) require clinic visits and have more stable levels; nasal and pellet options have different convenience/side-effect profiles.
• Risk increases with supraphysiologic or abusive dosing (bodybuilding use), not just therapeutic dosing.

Fertility-preserving options and alternatives

• If you want future children:
  • Sperm cryopreservation (banking) before starting TRT is a reliable option — companies: California Cryobank, Fairfax Cryobank, local hospital fertility labs.
  • Use of human chorionic gonadotropin (hCG) alongside TRT can maintain intratesticular testosterone and preserve sperm production better than TRT alone. hCG products: Pregnyl (urine-derived hCG), Ovidrel (recombinant).
  • Clomiphene citrate (Clomid) or enclomiphene: oral selective estrogen receptor modulators that raise endogenous testosterone without the same suppression of spermatogenesis in many men — often used as an alternative or to restart the HPT axis.
  • SERMs/hCG or medically supervised fertility protocols are best discussed with a reproductive urologist or endocrinologist.

Monitoring and baseline evaluation (what to get before/after starting)

• Baseline: morning total testosterone (two separate measurements), free testosterone if indicated, LH/FSH, prolactin (if low T and low gonadotropins), CBC (hematocrit), PSA, CMP (liver/kidney), fasting lipids, fasting glucose/HbA1c, and assess for sleep apnea and medication/health causes of low T.
• Ongoing: testosterone levels (timed to formulation), CBC/hematocrit every 3 months initially, then 6–12 months; PSA yearly (or per urologist); periodic lipid and metabolic checks; monitor symptoms and side effects.
• If hematocrit rises (commonly >50–54%), clinicians often reduce dose, change formulation, pause therapy or perform therapeutic phlebotomy.

Who should not use TRT (common contraindications)

• Known or suspected prostate or breast cancer.
• Uncontrolled severe heart failure, recent major cardiovascular events (discuss with cardiologist).
• Uncontrolled severe sleep apnea or untreated erythrocytosis.

Specific brands/formulations (examples and why)

• Injectable:
  • Depo-Testosterone (testosterone cypionate) — widely used, relatively inexpensive, administered IM; common dosing schedule.
  • Aveed (testosterone undecanoate) — long-acting IM injection (clinic-administered), more stable levels and less frequent dosing.
• Topical:
  • AndroGel, Testim (gels) — daily application, steady levels, risk of transfer to others.
  • Androderm (patch) — daily patch, steady delivery, can cause local irritation.
• Nasal:
  • Natesto — multiple daily doses, less risk of transference; some men find it convenient.
• Pellets:
  • Testopel — implanted subcutaneous pellets lasting months; requires minor procedure.
• Fertility/alternative meds:
  • Clomid (clomiphene citrate) — oral SERM often used to boost endogenous testosterone without the same suppression of fertility.
  • hCG products (Pregnyl, Ovidrel) — used to preserve testicular function or as part of fertility protocols.

Clinical next steps I recommend

1. See a qualified provider (endocrinologist or urologist experienced in male hormones). If you plan children, include a reproductive urologist or fertility specialist in the discussion.
2. Get baseline labs listed above (two morning T levels on different days).
3. If fertility is possible in your plans, consider sperm banking before starting TRT and ask about clomiphene or hCG-based options.
4. If you start TRT, follow a clear monitoring plan and report new symptoms promptly (chest pain, sudden shortness of breath, visual changes, thrombotic events, severe mood changes).

If you want, tell me:

• Are you already on TRT or considering it for low labs/symptoms?
• Do you plan to have biological children in the future? I can then suggest which formulations or strategies to discuss with your clinician and what specific labs to order.